Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
6 Months Ended | ||
---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
|
Research And Development Expenses | $ 3,300,000 | $ 2,900,000 | |
Deferred Revenue | 10,000,000.0 | ||
Cash and cash equivalents | 16,700,000 | ||
Amount held in money markey account | 10,200,000 | ||
Accounts Receivable | $ 8,489 | $ 12,510 | |
Warrants And Options [Member] | |||
Potentially Dilutive Securities Excluded From The Computation Of Eps | 6,460,018 |
X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Details
|